Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Efficacy of Itraconazole and Voriconazole in Cystic Fibrosis With Persistent Aspergillus
NCT01576315Phase 2Completed
- Sponsor
- CHU Rennes
- Start
- Jun 2014
- Primary completion
- Oct 2015
- Modality
- Orthosteric Ligands
- Countries
- 2
01
Overview
A Phase 2 trial of itraconazole, voriconazole in aspergillosis, sponsored by CHU Rennes. Started Jun 2014; status: completed.
02
Drugs
itraconazolevoriconazole
03
Conditions
aspergillosis
Beyond the preview
Go deeper on NCT01576315.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01576315.